Latest Earnings Results: Q2 '26
Estimated EPS
$4.95
Reported EPS
$9.38
Surprise
+89.34%
Estimated Rev
$215.03M
Reported Rev
$210.75M
Surprise
-1.99%
• Reported GAAP EPS of $9.58 up 424.75% YoY • Reported revenue of $210.75M down -13.62% YoY • Nutex Health anticipates the recent favorable changes to the HaloMD agreement and CMS administrative fees will lead to an approximate 25-30% reduction in normalized historical contract services expenses for Nutex Health.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | $5.71 | -- | -- | N/A |
Q2 '26 | $4.95 | $9.38 | 89.34% | BEAT |
Q1 '26 | $3.99 | $6.52 | 63.27% | BEAT |
Q4 '25 | $5.56 | $1.69 | -69.53% | MISSED |
Q3 '25 | $3.30 | $7.76 | 134.91% | BEAT |